Press release
Comprehensive Neurodegenerative Disease Market Forecast 2025-2034: Growth Trends and Strategic Shifts
Neurodegenerative Disease
Neurodegenerative Disease Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the neurodegenerative disease market has seen substantial growth. The market, which is projected to ascend from $52.3 billion in 2024 to $57.23 billion in 2025, is projected to increase at a compound annual growth rate (CAGR) of 9.4%. This expansion in past years has been encouraged by the advancement in diagnostic tools, escalated demand for remedies towards symptoms, an increase in clinical studies, growth in public-private associations, and an escalating burden of unaddressed healthcare requirements.
Neurodegenerative Disease Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, the neurodegenerative disease market is anticipated to experience robust expansion, reaching $81.23 billion in 2029 with a compound annual growth rate (CAGR) of 9.2%. This growth is expected thanks to advancements in gene and cell therapy, the growing use of digital biomarkers, the adoption of precision medicine techniques, an augmented pipeline of disease-modifying drugs, and the increasing application of artificial intelligence in neurology. Key trends to watch for include progress in neuroimaging technology, refined systems for drug delivery to the brain, the creation of customized treatment plans, innovation in biomarker identification, and enhancements in gene editing capabilities.
View the full report here:
https://www.thebusinessresearchcompany.com/report/neurodegenerative-disease-global-market-report
What Are the Drivers Transforming the Neurodegenerative Disease Market?
The neurodegenerative disease market is projected to experience significant growth due to an uptick in research and clinical trials. Clinical trials are research studies carried out with human subjects in order to examine the safety and effectiveness of new treatments, drugs or medical equipment. The surge in research and clinical trials can be attributed to the escalating demand for innovative treatments to cater to the changing health needs and enhance the quality of patient care. Clinical trials contribute to neurodegenerative disease research by offering valuable information on the safety and efficacy of new treatments which aids in advancing therapeutic development and improving patient results. For example, in November 2023, the Association of the British Pharmaceutical Industry (ABPI) reported a moderate increase of 4.3% in the number of industry clinical trials commencing annually in the UK, from 394 trials in 2021 to 411 in 2022. Consequently, the surge in research and clinical trials is likely to spur the growth of the neurodegenerative disease market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24618&type=smp
What Long-Term Trends Will Define the Future of the Neurodegenerative Disease Market?
Leading firms in the neurodegenerative disease market are channeling their efforts towards the creation of cutting-edge products like the next-generation adaptive Deep Brain Stimulation (aDBS) systems. The goal behind such development is to elevate the precision of treatment, boost the effects that modify the disease, and improve the patient's quality of life. Next generation adaptive deep brain stimulation (aDBS) systems are sophisticated neuro-modulating devices aimed towards providing real-time, custom treatment for Parkinson's disease. They work by fine-tuning stimulation parameters based on nervous system feedback, maximizing therapeutic results and reducing side effects, ultimately enhancing patient outcomes. For instance, in February 2025, Medtronic - a medical technology firm based in the US, earned the U.S. Food and Drug Administration (USFDA)'s approval for the world's first adaptive deep brain stimulation (aDBS) system devised for Parkinson's disease. This approval relates to the premarket approval (PMA) application for the Percept RC neurostimulator equipped with BrainSense technology. This tech automatically modifies therapy based on the patient's brain signals. It is clinically proven to provide symptom relief for patients suffering from advanced Parkinson's disease and indicates a significant progression in personalized neuromodulation therapies.
Which Segments in the Neurodegenerative Disease Market Offer the Most Profit Potential?
The neurodegenerative disease market covered in this report is segmented -
1) By Disease Type: Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Amyotrophic Lateral Sclerosis
2) By Drug Type: N-methyl-D-aspartate Receptor antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, Acetylcholinesterase (AChE) Inhibitors, Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor, Catechol-O-Methyltransferase (COMT) Inhibitor, Selective Serotonin Reuptake Inhibitor (SSRIs), Other Drug Types
3) By Route of Administration: Oral, Injectable, Transdermal, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
5) By End-User: Hospital, Retail, Online
Subsegment:
1) By Parkinson's Disease: Idiopathic Parkinson's Disease, Familial Parkinson's Disease, Early-Onset Parkinson's Disease, Parkinsonism
2) By Alzheimer's Disease: Early-Onset Alzheimer's Disease, Late-Onset Alzheimer's Disease, Familial Alzheimer's Disease (FAD), Inflammatory Subtype, Non-Inflammatory Subtype, Cortical Subtype
3) By Multiple Sclerosis (MS): Clinically Isolated Syndrome (CIS), Relapsing-Remitting MS (RRMS), Secondary Progressive MS (SPMS), Primary Progressive MS (PPMS), Progressive-Relapsing MS (PRMS)
4) By Huntington's Disease: Adult-Onset Huntington's Disease, Juvenile Huntington's Disease
5) By Amyotrophic Lateral Sclerosis (ALS): Classical ALS, Limb-Onset ALS, Bulbar-Onset ALS, Respiratory-Onset ALS, Primary Lateral Sclerosis (PLS), Progressive Muscular Atrophy (PMA), Juvenile ALS, ALS-Parkinsonism-Dementia Complex (ALS-PDC)
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24618&type=smp
Which Firms Dominate the Neurodegenerative Disease Market by Market Share and Revenue in 2025?
Major companies operating in the neurodegenerative disease market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, AbbVie Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck & Co. Inc., Biogen Inc., Neurocrine Biosciences Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Cassava Sciences Inc., Denali Therapeutics Inc., Voyager Therapeutics Inc., AC Immune SA, Amylyx Pharmaceuticals Inc., Sage Therapeutics Inc., Alzheon Inc.
Which Regions Offer the Highest Growth Potential in the Neurodegenerative Disease Market?
North America was the largest region in the neurodegenerative disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurodegenerative disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24618
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Comprehensive Neurodegenerative Disease Market Forecast 2025-2034: Growth Trends and Strategic Shifts here
News-ID: 4092117 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
